Obalon Therapeutics Inc (OBLN)


Stock Price Forecast

June 15, 2021


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Obalon Therapeutics Inc chart...

About the Company

Obalon Therapeutics, Inc. is a San Diego-based company focused on developing and commercializing novel technologies for weight loss.

CEO

Andrew Rasdal

Exchange

NASDAQ CAPITAL MARKET

Website

www.obalon.com

$1M

Total Revenue

34

Employees

$27M

Market Capitalization

-2.26

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $OBLN News

ReShape Lifesciences Inc (RSLS)

24d ago, source: Investing

IRVINE, Calif. - ReShape Lifesciences (NASDAQ:RSLS), a company specializing in weight loss and metabolic health solutions, has been granted a Notice of Allowance from the U.S.

Kim P. Kamdar's Net Worth

27d ago, source: Benzinga.com

Who is Kim P. Kamdar? Kim P. Kamdar has an estimated net worth of $2.25 Million. This is based on reported shares across multiple companies, which include MARINUS PHARMACEUTICALS INC, GLAUKOS Corp ...

FULC Fulcrum Therapeutics, Inc.

1d ago, source: Seeking Alpha

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high ...

Gilbert H Kliman's Net Worth

7d ago, source: Benzinga.com

Who is Gilbert H Kliman? Gilbert H Kliman has an estimated net worth of $887 Million. This is based on reported shares across multiple companies, which include AVEDRO INC, TESARO, Inc ...

ATXS Astria Therapeutics, Inc.

2d ago, source: Seeking Alpha

Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States.

Outlook Therapeutics, Inc. (OTLK)

2d ago, source: Yahoo Finance

ISELIN, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of ...

BioXcel Therapeutics Inc (BTAI) Stock: A SWOT Analysis

1d ago, source: newsheater

Steinhart Richard I, the Chief Financial Officer of BioXcel Therapeutics Inc, sale 1,069 shares at $2.63 during a trade that took place back on Apr 04 ’24, which means that Steinhart Richard I is ...

Revance Therapeutics, Inc. (RVNC)

3d ago, source: Yahoo Finance

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q4 2023 Earnings Call Transcript February 29, 2024 Revance Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the ...

Intellia Therapeutics Inc NTLA

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Cargo Therapeutics Inc CRGX

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Design Therapeutics, Inc.

11mon ago, source: CNN

Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small ...

Fate Therapeutics, Inc.

19d ago, source: CNN

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...